about
Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteersPharmacokinetics and safety assessments of high-dose and 4-week treatment with S-3304, a novel matrix metalloproteinase inhibitor, in healthy volunteers.Blocking cartilage destruction with metalloproteinase inhibitors: a valid therapeutic target?Tea polyphenols inhibit the activation of NF-κB and the secretion of cytokines and matrix metalloproteinases by macrophages stimulated with Fusobacterium nucleatum.
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Metalloproteinase inhibitors as therapeutics.
@en
type
label
Metalloproteinase inhibitors as therapeutics.
@en
prefLabel
Metalloproteinase inhibitors as therapeutics.
@en
P2093
P1476
Metalloproteinase inhibitors as therapeutics
@en
P2093
A H Drummond
J L Gordon
W A Galloway
P478
11 Suppl 8
P577
1993-03-01T00:00:00Z